|
1. |
Fibrinolysis and fibrinogenolysis in liver disease |
|
American Journal of Hematology,
Volume 34,
Issue 4,
1990,
Page 241-245
Hoyu Takahashi,
Wataru Tatewaki,
Ken Wada,
Hiroe Niwano,
Akira Shibata,
Preview
|
PDF (454KB)
|
|
摘要:
AbstractPatients with liver disease frequently have hemostatic abnormalities which include accelerated fibrinolysis. In order to assess the fibrinolytic state in liver disease, plasma levels of fibrinogenolysis products (FgDP), fibrinolysis products (FbDP), and fibrino‐genolysis plus fibrinolysis products (TDP) were measured with newly developed enzyme‐linked immunosorbent assays based on monoclonal antibodies in 36 patients with liver disease (six patients with acute hepatitis, seven with chronic hepatitis, ten with liver cirrhosis, 11 with hepatocellular carcinoma, and two with intrahepatic cholestasis). As compared with healthy subjects, mean plasma levels of FbDP (1,083 ± SD 1,254 vs. 236 ± 100 ng/ml,P= 0.005) and TDP (1,773 ± 1,814 vs. 669 ± 212 ng/ml,P= 0.001) were significantly elevated in patients with liver disease, whereas FgDP was normal (389 ± 202 vs. 396 ± 132 ng/ml,P= 0.87). Plasma FbDP correlated very well with TDP (r = 0.986,P<0.00001) in liver disease. In addition, FbDP and TDP but not FgDP correlated with plasma concentrations of thrombin‐antithrombin III complex. When plotted by the disease categories, the magnitude of elevations of FbDP and TDP was the most prominent in acute hepatitis followed by hepatocellular carcinoma. These findings indicate that activation of fibrinolysis occurs following thrombin generation, but increased primary fibrinogenolysis is rare in li
ISSN:0361-8609
DOI:10.1002/ajh.2830340402
出版商:Wiley Subscription Services, Inc., A Wiley Company
年代:1990
数据来源: WILEY
|
2. |
Infant leukemia: An analysis of nine chinese patients |
|
American Journal of Hematology,
Volume 34,
Issue 4,
1990,
Page 246-251
Wen‐Min Chuu,
Huei‐Fang Tien,
Dong‐Tsamn Lin,
Kai‐Hsin Lin,
Ih‐Jen Su,
Bow‐Wen Chen,
Kuo‐Sin Lin,
Der‐Cherng Liang,
Preview
|
PDF (549KB)
|
|
摘要:
AbstractA study was made of the cellular and molecular characteristics of nine Chinese infants, consecutively presenting with acute leukemia. Five cases were acute lymphoblastic leukemia (ALL); four were acute nonlymphoblastic leukemia (ANLL). Hyperleukocytosis, hepatosplenomegaly, and poor response to conventional therapy were common features, and CNS involvement was detected at diagnosis in three cases. The blast cells from all five cases with ALL expressed early B‐cell markers, i.e., HLA‐DR+, CD19 +, but CD10‐. Terminal deoxynucleotidyl transferase (TdT) was present in blasts from four of the five cases and periodic acid‐Schiff staining in blasts from two patients only. The leukemic cells of one patient also showed positive nonspecific esterase activity and expressed myeloid‐associated antigens CD33 (My9), CD11 (OkM1), and CD14 (My4 and Mo2). Molecular analysis of leukemic cell DNA from this and two other patients showed rearrangement of the immunoglobulin (Ig) heavy‐chain genes, but without any evidence of kappa light‐chain gene rearrangement. T‐cell receptor (TCR) genes remained in the germline configuration in these cases. Cytogenetic analysis showed translocation t(4;11) (q21;q23) in all four cases studied. In the group of ANLL, three cases belonged to the M4 and one to the M2 subtype. Chromosomal abnormality involving 11q23 was also detected in two patients: t(11;17)(q23;q11) and del(11)(q14q23) in each case respectively. Neither lg nor TCR gene rearrangement was present in blast cells from patients with ANLL. The data indicate that chromosomal rearrangement of band 11q23 was quite common in Chinese infants with either form of leukemia, a finding that may have pathogenet
ISSN:0361-8609
DOI:10.1002/ajh.2830340403
出版商:Wiley Subscription Services, Inc., A Wiley Company
年代:1990
数据来源: WILEY
|
3. |
Target cell of leukemic transformation in acute megakaryoblastic leukemia |
|
American Journal of Hematology,
Volume 34,
Issue 4,
1990,
Page 252-258
Tadashi Koike,
Masaru Urushiyama,
Miwako Narita,
Hiroshi Saitoh,
Fumihiro Ishida,
Shinsaku Imashuku,
Yoshihito Morioka,
Jiroh Utsumi,
Toshie Ishizuka,
Toshihisa Tsuruta,
Yutaka Takeuchi,
Makoto Kashimura,
Akira Shibata,
Preview
|
PDF (767KB)
|
|
摘要:
AbstractAcute megakaryoblastic leukemia (AMkL) is a newly defined acute leukemia in which the differentiation of proliferating blasts is arrested at the megakaryocytic precursor stage. In order to clarify whether a target cell of leukemic transformation in AMkL is a cell committed to megakaryocytic lineage, or a multipotential stem cell, we examined AMkL patients with regard to: a) the presence of myelodyplastic features in residual erythroid and granulocytic cells, b) coexistence of myeloperoxidase (MPO)‐positive blasts with megakaryoblasts, and c) the presence of the same chromosomal abnormality in erythroid and granuloid colony‐forming cells as seen in megakaryoblasts. Regarding the former two items, results were compared with those from megakaryoblastic crisis of chronic myelocytic leukemia (CML‐MkBC) and transient myeloproliferative disorder in Down syndrome (DS‐TMD), which are thought to be multipotential stem cell disorders. Among 18 patients with AMkL, three, all complicating myelofibrosis, had marked myelodysplastic changes of erythroid series and/or granulocytic series. In 4 out of 7 patients with CML‐MkBC, 5 out of 8 patients with DS‐TMD, and 7 out of 18 patients with AMkL, MPO‐positive blasts, even though rare, were observed in addition to PPO‐positive blasts. All except one of these patients with AMkL also showed complicating myelofibrosis. In one case of AMkL with myelofibrosis, chromosomal analysis of cultured cells of individual colonies revealed that all the analysable metaphases from both CFU‐GM and BFU‐E had the same chromosomal abnormality as megakaryoblasts. This study has clarified that a considerable proportion of AMkL cases, particularly those with complicating myelofibrosis or showing acute myelofibrosis, arise against the background of a multipotential stem cell disorder, even if blasts are exclusively megakary
ISSN:0361-8609
DOI:10.1002/ajh.2830340404
出版商:Wiley Subscription Services, Inc., A Wiley Company
年代:1990
数据来源: WILEY
|
4. |
Acetylcholinesterase in the human erythron. III. Regulation of differentiation |
|
American Journal of Hematology,
Volume 34,
Issue 4,
1990,
Page 259-261
Ronald D. Barr,
Marijke Koekebakker,
Preview
|
PDF (253KB)
|
|
摘要:
AbstractAcetylcholinesterase (AChE) is present in both primitive and mature erythroid cells, but a role for the enzyme in human hematopoiesis has not been defined. This prospect represented the primary objective of the following study. In clonal culture of normal human bone marrow cells, a “wave” of AChE activity was demonstrated, rising from undetectable levels to a peak (of 1.48 femto‐moles per min per cell) at 10 days in the course of progressive erythroid clonogenesis. At concentrations of enzyme inhibitor that clearly reduced AChE activity in a dose‐dependent fashion, there was no overall effect on erythropoiesis in vitro, but the clones were generally smaller and significantly more often multi‐focal than in control cultures. Furthermore, in the presence of AChE inhibitors, a concentration‐dependent increase in the myeloid‐erythroid ratios of the culture harvests was observed. Likewise, a clear reduction in hemoglobination was revealed, in cells of 10 day cultures, from a mean hemoglobin concentration of 35.0 pg per cell in controls to 20.1 pg per cell in the presence of the maximal concentration of the inhibitor (10−6M eserine). These data point to a role for AChE in the regulation of differentiation in the
ISSN:0361-8609
DOI:10.1002/ajh.2830340405
出版商:Wiley Subscription Services, Inc., A Wiley Company
年代:1990
数据来源: WILEY
|
5. |
Relationship of partially purified factor concentrates to immune tests and AIDS |
|
American Journal of Hematology,
Volume 34,
Issue 4,
1990,
Page 262-269
Janine Jason,
Robert C. Holman,
Bruce L. Evatt Group,
Preview
|
PDF (784KB)
|
|
摘要:
AbstractWe evaluated those members of a cohort of 203 hemophilic men providing all necessary information at their 1984 and 1985 evaluations, to determine whether non‐heated or<80°C dry heat‐treated partially purified factor products were associated with 1) the development of AIDS in human immunodeficiency virus (HIV)‐infected persons or 2) abnormal immune test results in participants seroconverting or remaining HIV seronegative. We found no relationship between type of factor (VIII vs. IX) (n = 162), frequency of usage (≧once a week vs.
ISSN:0361-8609
DOI:10.1002/ajh.2830340406
出版商:Wiley Subscription Services, Inc., A Wiley Company
年代:1990
数据来源: WILEY
|
6. |
Specific identification of fibrin(ogen) degradation products in plasma and serum using blotting and peroxidase labeled antiserum |
|
American Journal of Hematology,
Volume 34,
Issue 4,
1990,
Page 270-274
Anna B. Proietti,
Maura McGuire,
William Bell,
Preview
|
PDF (432KB)
|
|
摘要:
AbstractWe describe a method for identifying fibrinogen and fibrin split products using electrophoresis on agarose gel with sodium dodecyl sulfate (SDS) followed by blotting in nitrocellulose paper. Detection of these derivatives after blotting is accomplished with per‐oxidase‐conjugated rather than by isotopically labeled antibodies. This technique can detect diverse fibrinogen derivatives produced in vivo or in vitro by the combined action of thrombin, plasmin, and factor XIII. This methodology is applicable to plasma, serum, and other body fluids including urine and ascitic fluid. This sensitive and specific assay, distinguishing the products of cross‐linked fibrin from those of fibrinogen and detecting fibrin polymers in plasma, can be achieved without the use of radioact
ISSN:0361-8609
DOI:10.1002/ajh.2830340407
出版商:Wiley Subscription Services, Inc., A Wiley Company
年代:1990
数据来源: WILEY
|
7. |
Micromethod for demonstrating increased platelet surface immunoglobulin G: Findings in acute, chronic, and human immunodeficiency virus‐1‐related immunologic thrombocytopenias |
|
American Journal of Hematology,
Volume 34,
Issue 4,
1990,
Page 275-282
Dahlia Sthoeger,
Michael Nardi,
Susan Travis,
Margaret Karpatkin,
Simon Karpatkin,
Preview
|
PDF (632KB)
|
|
摘要:
AbstractA method has been developed for the demonstration of increased platelet surface IgG that uses 1 ml of blood regardless of the platelet count. Platelets are gel filtered to remove plasma and contaminating lymphocytes. They are then reacted with fluorescein‐conjugated antihuman IgG and analysed by flow cytometry. Percent positive staining cells vary from 10% to 80% of total cells examined. A platelet antibody index is derived from the product of percent positive staining cells X mean fluorescence intensity of positive staining cells. All patients studied with chronic idiopathic thrombocytopenia purpura (IIP) or human immunodeficiency virus‐1 (HIV‐1)‐related thrombocytopenia had increased platelet surface IgG. Twelve acute children and 11 chronic children had indices averaging 3.5‐and 8.9‐fold greater than 12 normal children, respectively. Five of 12 children with acute ITP had normal platelet IgG. There was no linear correlation between the platelet antibody index and platelet count. Platelets of patients with acute, chronic, or HIV‐1‐related ITP displayed autofluorescence. In chronic ITP, the percentage of platelets displaying auto‐fluorescence had a significant negative correlation with the platelet count. This technique will be a valuable diagnostic tool in the ped
ISSN:0361-8609
DOI:10.1002/ajh.2830340408
出版商:Wiley Subscription Services, Inc., A Wiley Company
年代:1990
数据来源: WILEY
|
8. |
Malignant mastocytosis with circulating mast cells |
|
American Journal of Hematology,
Volume 34,
Issue 4,
1990,
Page 283-286
Elizabeth Torrey,
Karen Simpson,
Stephen Wilbur,
Phillip Munoz,
Barry Skikne,
Preview
|
PDF (415KB)
|
|
摘要:
AbstractA case of malignant mastocytosis with peripheral blood involvement is presented. The course of the patient's illness was complicated by recurrent hypotensive episodes, presumed to have been caused by mast cell degranulation. Treatment with hydroxyurea was associated with persistent hypotension which resulted in death. It has been proposed that the diagnosis of mast cell leukemia be given to patients presenting with greater than 10% atypical mast cells in the blood. However, review of 16 published cases of malignant mastocytosis with circulating mast cells reveals that the clinical manifestations, complications, and survival do not vary significantly with the percentage of peripheral blood mast cells. Patients with malignant mastocytosis with significant involvement by atypical mast cells in the bone marrow and peripheral blood should be considered as having an aggressive disease, regardless of the precentage of circulating mast cells.
ISSN:0361-8609
DOI:10.1002/ajh.2830340409
出版商:Wiley Subscription Services, Inc., A Wiley Company
年代:1990
数据来源: WILEY
|
9. |
Iron overload in chinese patients with hemoglobin H disease |
|
American Journal of Hematology,
Volume 34,
Issue 4,
1990,
Page 287-290
Hui‐Chi Hsu,
Chung‐King Lin,
Shyh‐Haw Tsay,
Elizabeth Tse,
Chao‐Hung Ho,
Mo‐Ping Chow,
Chien‐Hui Yung,
Hong‐Wen Peng,
Preview
|
PDF (333KB)
|
|
摘要:
AbstractWe examined the iron status of 23 adult patients with hemoglobin H (Hb H) disease. None of them had received multiple blood transfusions or prolonged iron therapy. Studies included serum iron and ferritin concentrations, transferrin saturation, a desferrioxamine test, computed tomography (CT) scan of the liver, and liver biopsy. Iron overload was found in 17 patients (73.9%), especially in males and in patients with splenomegaly (92.9% and 100%, respectively). Four patients with excessive alcohol consumption had clinical manifestations of severe iron overload. Idiopathic hemochromatosis associated HLA antigens, i.e., HLA‐A3, ‐B7, or ‐B14, were not found in any of the 15 patients tested. These findings indicate that iron overload is common in adult patients with Hb H disease; such patients should abstain from alcohol and be considered for treatment with an iron chelating agent before irreversible organ damage o
ISSN:0361-8609
DOI:10.1002/ajh.2830340410
出版商:Wiley Subscription Services, Inc., A Wiley Company
年代:1990
数据来源: WILEY
|
10. |
Idiopathic myelofibrosis: A clinical study of 80 patients |
|
American Journal of Hematology,
Volume 34,
Issue 4,
1990,
Page 291-300
Hans Hasselbalch,
Preview
|
PDF (1028KB)
|
|
摘要:
AbstractA series of 122 consecutive patients with bone marrow fibrosis initially referred or categorized as idiopathic myelofibrosis is described. After a clinical and pathological review 14 patients were classified as postpolycythaemic myelofibrosis and 7 patients as a transitional myeloproliferative disorder. In 13 patients a diagnosis of hairy cell leukaemia was made, 3 patients had malignant tymphoma, 2 had malignant histiocytosis, and 1 patient had systemic lupus erythematosus with myelofibrosis. Two patients were excluded for further analysis owing to insufficient data.In the remaining 80 patients a diagnosis of idiopathic myelofibrosis was made. The clinical and laboratory findings in this series of patients are presented and compared to those in previous series. Infectious, cardiovascular, thromboembolic, and haemorrhagic complications were frequent, being recorded in 63%, 50%, 40%, and 33% of the patients, respectively. Various autoimmune phenomena were found in a proportion of the patients, but none had clinical evidence of connective tissue disease. Fifteen patients (19%) had a syndrome of acute myelofibrosis. The diagnostic criteria for this disease entity and its place within the spectrum of myeloproliferative disorders are discussed. In the present series acute myelofibrosis was found to encompass various transitional stages toward the evolution of acute leukaemia. It is proposed that acute or malignant myelofibrosis is considered as an acute variant of idiopathic myelofibrosis. Within this syndrome the acute variant seems to be far more common than previously recognized, which may also explain the marked clinical heterogeneity of the myelofibrosis/osteomyelosclerosis syndrome in this and most previous series.
ISSN:0361-8609
DOI:10.1002/ajh.2830340411
出版商:Wiley Subscription Services, Inc., A Wiley Company
年代:1990
数据来源: WILEY
|
|